The immune response in T1D patients is characterized by a type 1 immune response17, impaired function of regulatory T-lymphocytes18 and increased mRNA expression of interferon-gamma (IFN-γ)19, when compared to healthy individuals. The gene discussed is IFNG; the disease is type 1 diabetes mellitus.